logo
Share SHARE
FONT-SIZE Plus   Neg

Ionis Pharmaceuticals Posting Steep Loss In Afternoon Trading

After gapping open sharply lower, shares of Ionis Pharmaceuticals (IONS) continue to see significant weakness in afternoon trading on Monday. Ionis is currently down by 10 percent.

The steep drop by Ionis comes after the company reported positive results from a trial of its treatment for familial amyloid polyneuropathy but traders expressed concerns about side effects.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Denver, Colorado based low-cost carrier Frontier Airlines will expand its services to 21 cities. The airline which serves 80 cities in the U.S., Mexico and the Dominican Republic is planning to add 85 new routes. Abbott Laboratories (ABT) reported a profit for the second-quarter 2017 declined about 54.1 percent from last year, hurt by higher costs. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. Abbott raised its full-year 2017 earnings per share guidance range. Consumer goods giant Unilever plc reported Thursday higher profit in its first half, with increased sales and margin. Looking ahead, the company said it is on track for another year of underlying sales growth ahead of markets.
comments powered by Disqus
Follow RTT